The affected tube sizes including 2.0, 2.5, 3.0 and 3.5 mm, pose a serious risk of inadequate ventilation, which could lead to hypoxia, overdose, cardiopulmonary collapse or death, according to a March 10 news release from the FDA.
Affected customers and distributors have been notified and provided instructions for identifying the affected products. The company has received eight reports of serious injuries linked to this issue.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.